The main market opportunities lie in advancing protein engineering to develop innovative protein-based therapeutics, capitalizing on the pharmaceutical sector's demand for enhanced enzymes. This field ...
Protein engineering will be critical to creating the next generation of therapeutics, chemicals, materials, and food. Artificial intelligence is poised to have a transformational impact on protein ...
According to a recently published research paper by a team of scientists, a groundbreaking approach has been developed to create artificial allosteric sites (where by binding an effector molecule, ...
Biotech startup 10x Science has raised $4.8 million in seed funding to address a bottleneck in AI-driven drug discovery: the slow characterization of protein candidates. The company’s platform merges ...
In a remarkable leap forward for synthetic biology, the AI model ESM3, developed by Evolutionary Scale, has achieved a significant milestone. By simulating half a billion years of evolutionary ...
AlphaFold was published in 2021 and seemingly overnight effectively solved the protein folding problem, which had been an open challenge for decades. Since then, AI and ML methods have transformed the ...
Lawrence Livermore National Laboratory scientists have developed SpyCI-LAMBS, a high-throughput system that screens bacterial proteins for rare-earth element binding far faster than traditional ...
WHAT: The protein sequencing company, Quantum-Si, will discuss their novel next-generation protein sequencing platform, Platinum™, and how it can be used to identify proteins with single-molecule ...
Many pharmaceutical companies are using computer modeling programs to help design classes of drugs to fit into protein active sites. Researchers at Duke University are doing the opposite to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results